Lurasid 80mg Tablet (Lurasidone 80mg)

What is Lurasid 80mg Tablet (Lurasidone 80mg)?

Lurasid 80mg Tablet is an oral antipsychotic that delivers a standardized 80 mg dose of lurasidone per tablet. The drug is FDA-approved for the treatment of schizophrenia in adults and for maintenance therapy in bipolar I disorder. Lurasidone works by modulating dopamine D2 and serotonin 5-HT2A receptors, helping to reduce psychotic symptoms, mood instability, and depressive episodes. Clinical guidelines advise taking the tablet with a meal to improve bioavailability and to lessen gastrointestinal side effects.

Key features

• 80 mg dose — delivers a precise, consistent amount of lurasidone per tablet.
• Dual indication — approved for schizophrenia and bipolar I maintenance.
• Food-enhanced absorption — taken with a meal to maximize plasma levels.
• Once-daily dosing — supports adherence and simplifies regimens.
• Generic availability — offers a cost-effective alternative to brand-name products.
• Prescription-only — must be managed by a qualified psychiatrist.

Who is Lurasid 80mg Tablet (Lurasidone 80mg) for?

The medication is intended for adults diagnosed with schizophrenia who require long-term symptom control, as well as patients with bipolar I disorder who need a maintenance agent to prevent manic or depressive relapses. It is suitable for individuals who can adhere to a once-daily schedule and who are able to take the tablet with a substantial meal. Patients with severe hepatic impairment or a history of allergic reaction to lurasidone should avoid it, and clinicians will assess suitability on a case-by-case basis.

How does Lurasid 80mg Tablet (Lurasidone 80mg) compare?

Compared with older atypical antipsychotics such as olanzapine, lurasidone shows a lower propensity for weight gain and metabolic disturbances, though it requires food for optimal absorption. Generic formulations can reduce out-of-pocket costs, while long-acting injectable options from other drug classes provide an alternative adherence strategy for patients who struggle with daily pills. Overall, Lurasid offers a balanced efficacy-safety profile for clinicians seeking a moderate-risk antipsychotic. Its side-effect profile, including lower rates of sedation and extrapyramidal symptoms, makes it a viable option for patients sensitive to these adverse events. Regular monitoring of weight, lipids, and liver function is recommended throughout therapy.